Pediatrix Medical Group Inc (MD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.87 is considered Undervalued compared with the five-year average of 10.83. The fair price of Pediatrix Medical Group Inc (MD) is between 21.61 to 34.25 according to relative valuation method. Compared to the current price of 19.23 USD , Pediatrix Medical Group Inc By Undervalued By 11%.

Relative Value

Fair Zone

21.61-34.25

Current Price：19.23

11%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Pediatrix Medical Group Inc (MD) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Pediatrix Medical Group Inc (MD) has a current Price-to-Book (P/B) ratio of 2.01. Compared to its 3-year average P/B ratio of 1.30, the current P/B ratio is approximately 54.25% higher. Relative to its 5-year average P/B ratio of 1.75, the current P/B ratio is about 14.69% higher. Pediatrix Medical Group Inc (MD) has a Forward Free Cash Flow (FCF) yield of approximately 15.25%. Compared to its 3-year average FCF yield of 13.70%, the current FCF yield is approximately 11.35% lower. Relative to its 5-year average FCF yield of 9.89%, the current FCF yield is about 54.31% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for MD competitors is 1.05, providing a benchmark for relative valuation. Pediatrix Medical Group Inc Corp (MD.N) exhibits a P/S ratio of 0.92, which is -12.63% above the industry average. Given its robust revenue growth of -1.71%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of MD increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of MD in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is MD currently overvalued or undervalued?

Pediatrix Medical Group Inc (MD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.87 is considered Undervalued compared with the five-year average of 10.83. The fair price of Pediatrix Medical Group Inc (MD) is between 21.61 to 34.25 according to relative valuation method. Compared to the current price of 19.23 USD, Pediatrix Medical Group Inc is Undervalued By 11.00%.

What is Pediatrix Medical Group Inc (MD) fair value?

MD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Pediatrix Medical Group Inc (MD) is between 21.61 to 34.25 according to relative valuation method.

How does MD's valuation metrics compare to the industry average?

The average P/S ratio for MD's competitors is 1.05, providing a benchmark for relative valuation. Pediatrix Medical Group Inc Corp (MD) exhibits a P/S ratio of 0.92, which is -12.63% above the industry average. Given its robust revenue growth of -1.71%, this premium appears unsustainable.

What is the current P/B ratio for Pediatrix Medical Group Inc (MD) as of Mar 02 2026?

As of Mar 02 2026, Pediatrix Medical Group Inc (MD) has a P/B ratio of 2.01. This indicates that the market values MD at 2.01 times its book value.

What is the current FCF Yield for Pediatrix Medical Group Inc (MD) as of Mar 02 2026?

As of Mar 02 2026, Pediatrix Medical Group Inc (MD) has a FCF Yield of 15.25%. This means that for every dollar of Pediatrix Medical Group Inc's market capitalization, the company generates 15.25 cents in free cash flow.

What is the current Forward P/E ratio for Pediatrix Medical Group Inc (MD) as of Mar 02 2026?

As of Mar 02 2026, Pediatrix Medical Group Inc (MD) has a Forward P/E ratio of 9.87. This means the market is willing to pay $9.87 for every dollar of Pediatrix Medical Group Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Pediatrix Medical Group Inc (MD) as of Mar 02 2026?

As of Mar 02 2026, Pediatrix Medical Group Inc (MD) has a Forward P/S ratio of 0.92. This means the market is valuing MD at $0.92 for every dollar of expected revenue over the next 12 months.

MD Valuation